Evidence map›Paper›PMID 37050264›Full record

ReviewPolymers2023

Recent Developments and Formulations for Hydrophobic Modification of Carrageenan Bionanocomposites.

Rubie Mavelil-Sam, Elizabeth Mariya Ouseph, Marco Morreale, Roberto Scaffaro, Sabu Thomas

Abstract readReview
In one paragraph

Review in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Materials (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rubie Mavelil-SamSchool of Nanoscience and Nanotechnology, Mahatma Gandhi University, Kottayam 686 560, India.ORCID 0000-0002-0104-5599
Elizabeth Mariya OusephSchool of Energy Materials, Mahatma Gandhi University, Kottayam 686 560, India.ORCID 0009-0009-9835-1493
Marco MorrealeFaculty of Engineering and Architecture, Kore University of Enna, 94100 Enna, Italy.ORCID 0000-0002-7061-9103
Roberto ScaffaroDepartment of Engineering, University of Palermo, Viale delle Scienze, 90128 Palermo, Italy.ORCID 0000-0002-4830-0374
Sabu ThomasSchool of Nanoscience and Nanotechnology, Mahatma Gandhi University, Kottayam 686 560, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Versatility of the anionic algal polysaccharide carrageenan has long been discussed and explored, especially for their affinity towards water molecules. While this feature is advantageous in certain applications such as water remediation, wound healing, etc., the usefulness of this biopolymer is extremely limited when it comes to applications such as food packaging. Scientists around the globe are carrying out research works on venturing diverse methods to integrate hydrophobic nature into these polysaccharides without compromising their other functionalities. Considering these foregoing studies, this review is designed to have an in-depth understanding of diverse methods and techniques adopted for tuning the hydrophobic nature of carrageenan-based bionanocomposites, both via surface alterations or by changes made to their chemical structure and attached functional groups. This review article mainly focuses on how the hydrophobicity of carrageenan bionanocomposites varies as a function of the type and refinement of carrageenan, and with the incorporation of additives including plasticisers, nanofillers, bioactive agents, etc. Incorporation of nanofillers such as polysaccharide-based nanoparticles, nanoclays, bioceramic and mineral based nanoparticles, carbon dots and nanotubes, metal oxide nanoparticles, etc., along with their synergistic effects in hybrid bionanocomposites are also dealt with in this comprehensive review article.

Indexed as

bioactive agentsbionanocompositescarrageenanhydrophobicitynanofillers

Identifiers

PMID37050264
PMCPMC10097169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.